Suraj Kalia

Q: What is Suraj Kalia's success rate?

Suraj Kalia currently has a success rate of 99.04463095144716.

Q: What is the average return of Suraj Kalia's calls?

Their stock ratings have generated an average return of 17.145042049569245.

Oppenheimer | Healthcare

Suraj Kalia is an analyst from Oppenheimer specializing in the Healthcare sector. Ranked #770 out of 4655 analysts, they have issued 15 stock ratings with a success rate of 99.04% and an average return of 17.15%.

With 15 ratings to date, Suraj Kalia is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 99.04% and an average return of 17.15%, highlighting promising potential as their track record develops further.

#770

Out of 4655

Total Ratings

+99.04%

Success Rate

+17.15%

Average Return

Recent Ratings Analysis

ITGR

Buy

May 13, 2026

Target

$115.00

Current

$84.98

Performance

—

Suraj Kalia rated ITGR as Outperform on May 13, 2026, setting a price target of 115. Shares have remained stable near 84.98, leaving the 115 target still in play.

PODD

Buy

May 07, 2026

Target

$210.00

Current

$158.35

Performance

-1.28%

On May 07, 2026, PODD was given a Outperform rating by Suraj Kalia, with a target price of 210. The stock traded sideways with a -1.28% move, keeping the bullish thesis unresolved.

ABT

Buy

Apr 17, 2026

Target

$115.00

Current

$84.38

Performance

-12.84%

ABT received a Outperform rating from Suraj Kalia on Apr 17, 2026, aiming for 115. The rating hasn’t played out as hoped, with the stock trading 12.84% below expectations.

PRCT

Hold

Feb 26, 2026

Target

—

Current

$28.69

Performance

21.41%

On Feb 26, 2026, Suraj Kalia published a Perform outlook on PRCT, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

TMDX

Buy

Feb 25, 2026

Target

$175.00

Current

$63.93

Performance

-51.51%

Suraj Kalia on Feb 25, 2026 assigned TMDX a Outperform rating, with a price target of 175. The call has struggled to gain traction, with shares losing 51.51%.

ATRC

Hold

Feb 18, 2026

Target

—

Current

$26.69

Performance

-17.27%

On Feb 18, 2026, Suraj Kalia reaffirmed ATRC with a Perform rating, targeting null. The Hold stance reflected market caution that was later justified.

BSX

Buy

Jan 16, 2026

Target

$100.00

Current

$54.10

Performance

-38.57%

BSX was rated Outperform by Suraj Kalia on Jan 16, 2026, with a price objective of 100. This case shows how bullish projections can fail, with the stock now below 54.1.

INSP

Buy

Dec 08, 2025

Target

$175.00

Current

$44.06

Performance

-69.40%

On Dec 08, 2025, Suraj Kalia initiated coverage on INSP with a Outperform rating and target of 175. The Buy call has yet to be validated as shares remain 130.94 away from the target.

VREX

Buy

Nov 19, 2025

Target

$18.00

Current

$9.87

Performance

-3.61%

Suraj Kalia issued a Outperform recommendation for VREX on Nov 19, 2025, price target set at 18. The target of 18 remains in play, though confirmation will depend on future moves.

EW

Hold

Oct 08, 2025

Target

—

Current

$79.73

Performance

5.27%

On Oct 08, 2025, EW was evaluated by Suraj Kalia, who gave a Perform rating and target of null. Investors who stayed in despite the Hold saw upside of 5.27%.

PLSE

Buy

Jul 07, 2025

Target

$22.00

Current

$23.30

Performance

47.38%

Suraj Kalia rated PLSE as Outperform on Jul 07, 2025, setting a price target of 22. The call has proven timely, with shares rising 47.38% toward the price target of 22.

IRTC

Buy

Jan 08, 2025

Target

$120.00

Current

$118.31

Performance

27.22%

On Jan 08, 2025, IRTC was given a Outperform rating by Suraj Kalia, with a target price of 120. The stock rallied 27.22% after the rating, narrowing the gap to the target of 120 and validating the bullish stance.

TLSI

Buy

Sep 16, 2024

Target

$10.00

Current

$4.56

Performance

-2.36%

TLSI received a Outperform rating from Suraj Kalia on Sep 16, 2024, aiming for 10. Price action was muted, as shares hovered around 4.56 despite the bullish outlook.

RMD

Hold

Jun 25, 2024

Target

—

Current

$203.79

Performance

10.85%

On Jun 25, 2024, Suraj Kalia published a Perform outlook on RMD, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

NYXH

Buy

Mar 14, 2024

Target

$20.00

Current

$3.07

Performance

-81.48%

Suraj Kalia on Mar 14, 2024 assigned NYXH a Outperform rating, with a price target of 20. The call has struggled to gain traction, with shares losing 81.48%.

Frequency Asked Questions

Who is Suraj Kalia?

Suraj Kalia is an analyst from Oppenheimer specializing in the Healthcare sector.

What is Suraj Kalia's success rate?

Suraj Kalia currently has a success rate of +99.04%.

How many ratings has Suraj Kalia issued?

Suraj Kalia has issued 15 stock ratings so far.

What is the average return of Suraj Kalia's calls?

Their stock ratings have generated an average return of +17.15%.

What is Suraj Kalia's ranking?

Suraj Kalia is ranked #770 out of 4655 analysts.

What types of ratings does Suraj Kalia give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Suraj Kalia?

You can follow Suraj Kalia by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Suraj Kalia?

Their latest rating was a Buy on ITGR issued on 2026-05-13.